ONCOLOGY_HEADER

MEDICAMEN BIOTECH LIMITED IS NOW NSE LISTED

WE ARE NOW NSE LISTED!

Medicamen Biotech Limited is now NSE LISTED

ONCOLOGY_HEADER

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

Poised to launch novel oncology products

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

ONCOLOGY_HEADER

Haridwar Unit 1 for formulations is WHO GMP approved

WHO GMP approved

Haridwar Unit 1 for formulations is WHO GMP approved

ONCOLOGY_HEADER

ANDA filing for oncology formulations in process

Abbreviated New Drug Application (ANDA) filing process

ANDA filing for oncology formulations in process

Neque porro quisquam est

Consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

24

Sed ut perspiciatis

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur

32

The idea

Wellness in Ark!

38

Stunning design

Always something new!